European economic rebound slows as virus cases rise
LONDON — The European economy's rebound from the coronavirus recession appears to have slowed in August as a resurgence in new confirmed contagions across...
Discussions with Russia on COVID-19 vaccine under way
LONDON — The World Health Organization’s Europe office said it has begun discussions with Russia to try to obtain more information about the experimental...
Millions of women lose contraceptives, abortions in COVID-19
NEW DELHI (AP) — Millions of women and girls globally have lost access to contraceptives and abortion services because of the coronavirus pandemic. Now...
Many steps needed for accurate COVID-19 test results
WASHINGTON — A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if...
Universities scramble to deal with virus outbreaks
North Carolina's flagship university canceled in-person classes for undergraduates just a week into the fall semester Monday as college campuses around the U.S. scramble...
Chris Swifte to join AP Group as its new National Business Development Manager
AP Group is proud to announce the appointment of Chris Swifte as its new National Business Development Manager, effective 1 September 2020.
Chris is a...
New Zealand delays election after virus outbreak in Auckland
WELLINGTON, New Zealand — Prime Minister Jacinda Ardern on Monday chose to delay New Zealand's national elections by four weeks as the country deals...
Study hints, can’t prove, survivor plasma fights COVID-19
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it’s not proof and some experts...
Experts warn Spain is losing the 2nd round in virus fight
BARCELONA, Spain — Not two months after battling back the coronavirus, Spain’s hospitals have started seeing patients who are struggling to breathe returning to...
Companies test antibody drugs to treat, prevent COVID-19
With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to...
- Advertisement -
